If you have PCOS and are in your 40s, you are navigating one of the most underserved areas in women’s health: the convergence of two hormonal conditions that share symptoms, amplify each other’s risks: PCOS and Perimenopause. These two are rarely addressed together in a coherent clinical framework.
PCOS does not disappear at menopause. It is a lifelong metabolic and hormonal condition. And perimenopause – the 4 to 10 year transition before your final menstrual period – brings its own set of hormonal disruptions that can overlap confusingly with PCOS, or actively worsen it. Understanding this overlap is essential for managing your health well through this transition.
As someone who has PCOS and has navigated this transition alongside my patients, I find this topic both personally and clinically urgent.
Does PCOS Get Better or Worse with Age?
The answer is: it depends on which PCOS features we are talking about.
Menstrual regularity may improve: Many women with PCOS notice that their cycles become more regular in their late 30s and 40s. This is thought to be related to the natural decline in ovarian reserve and to a gradual decrease in the extreme androgen-driven follicular disruption seen in earlier reproductive years.
Androgen excess often persists: Research shows that elevated testosterone, free androgen index, and androstenedione continue into perimenopause and post-menopause in women with PCOS. A 2023 systematic review and meta-analysis in Human Reproduction Update found that peri- and postmenopausal women with PCOS had significantly higher total testosterone, free androgen index, and androstenedione than age-matched controls, even after adjusting for BMI.
Metabolic risk escalates: The PCOS and perimenopause period is associated with increased insulin resistance, weight redistribution toward abdominal fat, worsening lipid profiles, and elevated cardiovascular risk. For women with PCOS who already have these metabolic vulnerabilities, perimenopause can act as an amplifier. Women with PCOS and perimenopause have a significantly higher risk of impaired glucose tolerance and type 2 diabetes as they move through this transition.
Why Perimenopause Is Hard to Distinguish from PCOS
This is one of the most clinically challenging aspects of this overlap. Both PCOS and perimenopause can cause:
- Irregular menstrual cycles
- Sleep disturbances
- Mood changes, anxiety, and depression
- Weight gain, particularly abdominal
- Fatigue
- Low libido
- Skin and hair changes
Interestingly, some research suggests that women with PCOS and perimenopause are less likely to experience severe hot flushes – possibly related to their chronically higher androgen levels – but are more likely to experience vaginal dryness and testosterone-deficiency symptoms (brain fog, memory issues, reduced stamina) as their previously high androgen levels decline.
Women with PCOS also reach menopause an average of 2 – 4 years later than women without PCOS, which is thought to be related to higher ovarian follicle counts. This means the perimenopausal transition may begin later and last longer.
The Long-Term Health Picture
This is where I want to be direct with you about risk, because knowledge is the foundation of proactive care.
Women with PCOS and perimenopause carry elevated risks for:
- Type 2 diabetes: The Study of Women’s Health Across the Nation (SWAN) found that women with PCOS and perimenopause had a significantly higher prevalence of impaired glucose tolerance in the perimenopausal years (25% vs. 9.2% in controls). This is a well-established finding and one of the strongest arguments for maintaining insulin-sensitizing strategies throughout life, not just during the reproductive years.
- Cardiovascular disease: Women with PCOS have higher rates of hypertension, dyslipidemia (low HDL, elevated triglycerides), and subclinical atherosclerosis. The 2023 systematic review found elevated odds ratios for myocardial infarction and stroke in postmenopausal women with PCOS. The cardiometabolic risk is substantially driven by the co-occurrence of excess weight, but risks persist even in lean PCOS.
- Endometrial cancer: Women with PCOS and perimenopause who have had chronic anovulation (absent ovulation) are exposed to unopposed estrogen, which increases endometrial cancer risk. If you have had long periods of absent menses due to PCOS, this is an important screening consideration.
- Cognitive changes: Emerging research suggests that midlife women with PCOS (ages 48–60) may experience more pronounced cognitive decline than women without PCOS, likely related to insulin resistance and vascular risk.
Managing PCOS Through Perimenopause: An Evidence-Based Approach
Continue insulin-sensitizing strategies
This is the most important message I can offer: do not stop your PCOS management strategies because your periods are becoming irregular or because you think PCOS is ‘resolving.’ The metabolic underpinnings of PCOS, insulin resistance, androgen excess, and inflammation do not resolve with age, and the perimenopausal hormonal environment can worsen them.
Dietary approaches that stabilize blood glucose and insulin (low-carb, low-glycemic-load, anti-inflammatory, adequate protein and fibre) remain the cornerstone. Resistance exercise, which directly improves insulin sensitivity and preserves lean muscle mass during the hormonal changes of perimenopause, becomes even more important.
Review your PCOS supplement protocol
Myo-inositol, magnesium, vitamin D, and omega-3 fatty acids remain relevant and evidence-supported through perimenopause and beyond. Berberine (an evidence-based insulin sensitizer) is worth discussing with your naturopath if insulin resistance is a significant ongoing concern, as it has evidence for both cardiometabolic and glucose-lowering effects.
Monitor relevant labs
Annual fasting insulin, glucose, HbA1c, full lipid panel, blood pressure, and a cardiometabolic risk assessment become more important, not less, as you move through this transition. If you have a history of irregular periods due to PCOS, periodic discussion about endometrial surveillance with your gynecologist is also appropriate.
The Bottom Line on PCOS and Perimenopause
PCOS in perimenopause is not a niche concern; it is the lived reality of millions of women who were diagnosed (or should have been diagnosed) in their 20s and 30s, and who are now moving into a life stage that brings its own hormonal complexity. Menopause does not cure PCOS. The metabolic and androgenic features persist, and the cardiometabolic risks escalate.
The good news is that the same strategies that managed your PCOS well in your younger years, anti-inflammatory nutrition, blood sugar stability, targeted supplementation, and appropriate movement, remain effective and become even more important. Perimenopause is a transition, not an endpoint, and proactive management now pays dividends in long-term health.
References on PCOS and Perimenopause:
Millan-de-Meer M et al. (2023). PCOS during the menopausal transition and after menopause: systematic review and meta-analysis. Hum Reprod Update 29(6):741-772. PMID: 37353908
Sharma S & Mahajan N. (2021). PCOS and Menopause in Forty-Plus Women. J Mid-life Health 12(1):3-7. PMC8189332
Lenart-Lipińska M, Matyjaszek-Matuszek B, Woźniakowska E, Solski J, Tarach JS, Paszkowski T. Polycystic ovary syndrome: clinical implications in perimenopause. Prz Menopauzalny. 2014 Dec;13(6):348-51. doi: 10.5114/pm.2014.47988. Epub 2014 Dec 30. PMID: 26327878; PMCID: PMC4352911.
Shah D, Rasool S. Polycystic Ovary Syndrome (PCOS) Transition at Menopause. J Midlife Health. 2021 Jan-Mar;12(1):30-32. doi: 10.4103/jmh.jmh_37_21. Epub 2021 Apr 17. PMID: 34188423; PMCID: PMC8189337.
